Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11969421 Bupropion as a modulator of drug activity

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
June 15, 2022
0
Date of Patent
April 30, 2024
0
Patent Application Number
17841274
0
Patent Citations
‌
US Patent 11357744 Bupropion as a modulator of drug activity
0
‌
US Patent 11628149 Bupropion as a modulator of drug activity
0
‌
US Patent 11660273 Dosage forms and methods for enantiomerically enriched or pure bupropion
0
‌
US Patent 11660274 Dosage forms and methods for enantiomerically enriched or pure bupropion
0
‌
US Patent 11752144 Compounds and combinations thereof for treating neurological and psychiatric conditions
0
‌
US Patent 11779579 Bupropion as a modulator of drug activity
0
‌
US Patent 11839612 Compounds and combinations thereof for treating neurological and psychiatric conditions
0
‌
US Patent 11883373 Treatment of depression in certain patient populations
0
‌
US Patent 6897241 Preparation of topical regional compositions for the relief of pain
0
‌
US Patent 7569610 Modified release formulations of a bupropion salt
0
•••
Patent Citations Received
‌
US Patent 12109178 Bupropion as a modulator of drug activity
0
Patent Inventor Names
Herriot Tabuteau
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11969421
0
Patent Primary Examiner
‌
Raymond J. Henley, III
0
CPC Code
‌
A61K 31/439
0
‌
A61K 31/165
0

Find more entities like US Patent 11969421 Bupropion as a modulator of drug activity

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo